Traditional oral weight loss medications mainly included drugs that suppressed appetite or inhibited fat absorption, but the market is now being defined by new oral GLP-1 receptor agonists, incretin dual agonists, triple agonists, and other metabolic disease medications
Key Considerations for Coverage Decisions: If you limit or remove GLP-1 coverage, make sure the criteria are clear, consistently applied, and well-documented
Bottom line: Medications are tools that make it easier to stick to a lifestyle plan
Do not adjust your dosage or stop taking the medication without consulting your healthcare provider
Youll feel the difference within minutes of completing the session
Thus, the objective of this research was to examine the effects the low glutamate diet on anxiety, PTSD, and depression in veterans with GWI